LPOXY Therapeutics Highlights C. diff Awareness Month with Innovative Oral Preventive Therapy Trials In honor of C. diff Awareness Month, LPOXY Therapeutics is advancing its oral preventive therapy SIDIPREV™ towards pivotal trials, addressing a serious public health concern.

LPOXY Therapeutics Highlights C. diff Awareness Month with Innovative Oral Preventive Therapy Trials #USA #Platte_City #C._diff #LPOXY #SIDIPREV

Fighting C difficile Before It Starts: Lopoxy Therapeutics Approach CEO Larry Sutton, MD, PhD, discusses SIDIPREV, a novel oxygen-based therapy aimed at preventing C difficile infections.

In the first part of our interview with Dr. Larry Sutton CEO of LPOXY Therapeutics, we discuss SIDIPREV, an oxygen-based therapy designed to prevent #Cdifficile infections in high-risk patients. #CDiff #SIDIPREV #IDsky #MEDsky

Listen here: www.contagionlive.com/view/fightin...